Muhammad Mohsin

Evaluation of clinical manifestations, health risks, and quality of life among women with polycystic ovary syndrome

Syeda Sidra, Muhammad Haseeb Tariq, Muhammad Junaid Farrukh et al. · PLoS ONE · 2019 · 113 citations · Full text

Medicine, Endocrinology, Gynecology +14

Coronary sinus reducer for the treatment of refractory angina (ORBITA-COSMIC): a randomised, placebo-controlled trial

Michael Foley, Christopher Rajkumar, Fiyyaz Ahmed‐Jushuf et al. · The Lancet · 2024 · 83 citations · Full text

Medicine, Cardiology, Pharmacotherapy +14

Independent validation and clinical implications of the risk prediction model for long QT syndrome (1-2-3-LQTS-Risk)

Andrea Mazzanti, Alessandro Trancuccio, Deni Kukavica et al. · EP Europace · 2021 · 56 citations

Medicine, Cardiology, Internal Medicine +17

In Vitro Investigation and Evaluation of Novel Drug Based on Polyherbal Extract against Type 2 Diabetes

Zainab Riaz, Murtaza Najabat Ali, Zunaira Qureshi et al. · Journal of Diabetes Research · 2020 · 36 citations · Full text

Pharmacy, Pharmaceutics, Pharmacology +17

Symptoms as a Predictor of the Placebo-Controlled Efficacy of PCI in Stable Coronary Artery Disease

Florentina Simader, Christopher Rajkumar, Michael Foley et al. · Journal of the American College of Cardiology · 2024 · 36 citations

Medicine, Cardiology, Clinical Cardiology +10